Exogenous Ochronosis.

Indian J Dermatol

Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India.

Published: December 2015

Exogenous ochronosis (EO) is a cutaneous disorder characterized by blue-black pigmentation resulting as a complication of long-term application of skin-lightening creams containing hydroquinone but may also occur due to topical contact with phenol or resorcinol in dark-skinned individuals. It can also occur following the use of systemic antimalarials such as quinine. EO is clinically and histologically similar to its endogenous counterpart viz., alkaptonuria, which, however, exhibits systemic effects and is an inherited disorder. Dermoscopy and in vivo skin reflectance confocal microscopy are noninvasive in vivo diagnostic tools. It is very difficult to treat EO, a cosmetically disfiguring and troubling disorder with disappointing treatment options.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681189PMC
http://dx.doi.org/10.4103/0019-5154.169122DOI Listing

Publication Analysis

Top Keywords

exogenous ochronosis
8
ochronosis exogenous
4
ochronosis cutaneous
4
cutaneous disorder
4
disorder characterized
4
characterized blue-black
4
blue-black pigmentation
4
pigmentation complication
4
complication long-term
4
long-term application
4

Similar Publications

Melasma is a challenging, acquired hyperpigmentary disorder. The gold standard treatment is Kligman's formulation, which contains hydroquinone, tretinoin, and dexamethasone, but its long-term use is limited by the risk of exogenous ochronosis. Cysteamine, a tyrosinase inhibitor, reduces melanocyte activity and melanin production, showing strong depigmenting effects in patients resistant to Kligman's formulation.

View Article and Find Full Text PDF

Alkaptonuria (AKU) is an extremely rare autosomal recessive metabolic disorder caused by deficiency of homogentisic acid oxidase and resulting in accumulation of homogentisic acid in collagenous structures. It is characterized by a triad of homogentisic aciduria, bluish-black discoloration of connective tissues (ochronosis) and arthropathy of large weight bearing joints. We report on a middle-aged female patient with bilateral severe ochronotic arthritis of both hips and shoulder joints requiring total joint replacements as staged procedures which were done without complications offering a complete pain relief and a satisfactory clinical and functional outcome.

View Article and Find Full Text PDF
Article Synopsis
  • Alkaptonuric ochronosis is a condition caused by the buildup of homogentisic acid in body tissues, often associated with the rare genetic disorder alkaptonuria due to a specific enzyme deficiency.
  • A case report describes a 64-year-old woman with serious heart issues who exhibited ochronotic pigmentation in her heart valves and surrounding structures, highlighting the condition's impact on cardiovascular health.
  • This case underscores the importance of considering ochronosis as a potential factor in diagnosing valvular diseases even when a patient hasn’t been previously diagnosed with alkaptonuria.
View Article and Find Full Text PDF

Exogenous Ochronosis With Vitiligo: A Therapeutic Challenge.

Skin Res Technol

October 2024

Department of Dermatology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!